Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
November 13, 2017
Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2018 Results; Teleconference and Webcast to be held on November 13, 2017
CRANBURY, N.J., Nov. 13, 2017 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases ...
November 13, 2017
Reata Pharmaceuticals, Inc. Announces Third Quarter 2017 Financial and Operating Results
IRVING, Texas, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA) (Reata or Company), a clinical-stage biopharmaceutical company, today announced financial results for the ...
November 13, 2017
Eiger BioPharmaceuticals to Present at Jefferies 2017 Healthcare Conference
PALO ALTO, Calif., Nov. 13, 2017 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for orphan diseases, announced today that ...
November 13, 2017
CymaBay Therapeutics to Present at Three Investor Conferences
NEWARK, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
November 13, 2017
ADMA Biologics Announces Closing of $42M Follow-On Offering
RAMSEY, N.J. and BOCA RATON, Fla., Nov. 13, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical ...
November 10, 2017
VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at SITC 2017
CAMBRIDGE, Mass., Nov. 10, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (VBIV) (VBV.TO) (VBI) today announced that Catalina Soare, VBI’s head of preclinical development, will ...
November 10, 2017
Kamada Announces Nomination of Three New Members to its Board of Directors
REHOVOT, Israel, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Kamada Ltd. (KMDA) (KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announced today that the ...
November 10, 2017
Arena Pharmaceuticals Completes Full Enrollment in Etrasimod Phase 2 Clinical Study for Ulcerative Colitis
SAN DIEGO, Nov. 10, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), today announced that it has completed full enrollment in the etrasimod Phase 2 study in ulcerative ...
November 9, 2017
Galmed Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
TEL AVIV, Israel, Nov. 9, 2017 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of a once-daily, ...
November 9, 2017
CytoSorbents Recognized on Deloitte's 2017 Technology Fast 500™ as One of the Fastest Growing Companies in North America
MONMOUTH JUNCTION, N.J., Nov. 9, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO) announced that at last evening's awards ceremony, it ranked 7th amongst 21 medical device companies, ...
November 9, 2017
New Peer Reviewed Publication Shows That BrainStorm's NurOwn® Has a Unique miRNA Signature
HACKENSACK, N.J. and PETACH TIKVAH, Israel, Nov. 9, 2017 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced ...
November 9, 2017
Eiger BioPharmaceuticals Reports Third Quarter 2017 Financial Results
PALO ALTO, Calif., Nov. 9, 2017 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today ...
November 9, 2017
Albireo to Present at the Jefferies 2017 London Healthcare Conference
BOSTON, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
November 9, 2017
iCAD Announces Positive Clinical Data on Xoft System for Non-Melanoma Skin Cancer Treatment Selected as “Best of ASTRO 2017”
NASHUA, N.H. and MIAMI, Nov. 09, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today ...
November 9, 2017
VBL Therapeutics to Present at the 22nd Annual Scientific Meeting of the Society for Neuro-Oncology (SNO) on November 18
TEL AVIV, Israel, Nov. 09, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class ...
November 9, 2017
Advaxis to Present at the Jefferies 2017 London Healthcare Conference
PRINCETON, N.J.--(BUSINESS WIRE)--Advaxis, Inc. (ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announces that company management will participate in ...
November 9, 2017
Prometic to Report its Third Quarter 2017 Financial Results and to Hold Conference Call / Webcast
LAVAL, QC, Nov. 9, 2017 /PRNewswire/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) ("Prometic") today announced that it will report its financial results for the ...
November 9, 2017
UroGen Pharma to Present at the Jefferies 2017 London Healthcare Conference
RA’ANANA, Israel and NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs ...
November 9, 2017
ADMA Biologics Announces Pricing of Follow-On Offering
RAMSEY, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company ...
November 9, 2017
Rexahn Pharmaceuticals to Present at the Stifel 2017 Healthcare Conference
ROCKVILLE, Md., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, ...
Page 99 of 138